Aclaris Therapeutics
ACRS
ACRS
126 hedge funds and large institutions have $1.02B invested in Aclaris Therapeutics in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 51 increasing their positions, 36 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
5% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 22
2% less funds holding
Funds holding: 128 → 126 (-2)
1.93% less ownership
Funds ownership: 94.68% → 92.76% (-1.9%)
Holders
126
Holding in Top 10
8
Calls
$2.33M
Puts
$807K
Top Buyers
| 1 | +$13M | |
| 2 | +$10.7M | |
| 3 | +$10M | |
| 4 |
BlackRock
New York
|
+$9.89M |
| 5 |
CC
Commodore Capital
New York
|
+$9.38M |
Top Sellers
| 1 | -$16.6M | |
| 2 | -$11.9M | |
| 3 | -$9M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$7.8M |
| 5 |
Renaissance Technologies
New York
|
-$7.4M |